ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,416,636, issued on Sept. 16, was assigned to UNIVERSITY OF FLORIDA RESEARCH FOUNDATION INC. (Gainesville, Fla.).
"Personalized treatment of pancreatic cancer" was invented by Steven J. Hughes (Gainesville, Fla.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein is a soluble protein signature from the tumor microenvironment that can predict overall survival post-surgery in pancreatic adenocarcinoma. The disclosed protein signatures provide a precision approach to surgical therapy for patients with pancreatic cancer. Also disclosed herein is a soluble protein signature from the tumor microenvironment that can diagnose pancreatic ductal adeno...